Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Horby

Showing results (11-20 of 190) with videos related to

Pageof 19
Sort By:
The Lancet. Infectious Diseases|May 3, 2017
Insights from clinical research completed during the west Africa Ebola virus disease epidemicAmanda Rojek, Peter Horby, Jake Dunning
Advances in Biological Regulation|August 1, 2022
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trialLeon Peto, Peter Horby, Martin Landray
Science Bulletin|February 28, 2022
COVID-19 can be called a treatable disease only after we have antiviralsXueyang Zhang, Peter Horby, Bin Cao
Emerging Infectious Diseases|January 23, 2019
International Biological Reference Preparations for Epidemic Infectious DiseasesTommy Rampling, Mark Page, Peter Horby
Lancet (London, England)|April 6, 2024
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' replyLeon Peto, Buddha Basnyat, Peter Horby
Vaccine|May 20, 2004
Using computer simulations to compare pertussis vaccination strategies in AustraliaHerbert W Hethcote, Peter Horby, Peter McIntyre
Singapore Medical Journal|October 3, 2014
The potential for a controlled human infection platform in SingaporeShobana Balasingam, Peter Horby, Annelies Wilder-Smith
Lancet (London, England)|April 11, 2008
Person-to-person transmission of influenza A (H5N1)Tran Hien Nguyen, Jeremy Farrar, Peter Horby
BMJ (Clinical Research Ed.)|October 2, 2009
Online video sharing and patients' privacyHeiman F L Wertheim, Jeremy Farrar, Peter Horby
Communicable Diseases Intelligence Quarterly Report|September 27, 2003
Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000Peter Horby, Robin Gilmour, Han Wang, et al.
Pageof 19

Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
The Lancet. Infectious Diseases|May 3, 2017
Insights from clinical research completed during the west Africa Ebola virus disease epidemicAmanda Rojek, Peter Horby, Jake Dunning
Advances in Biological Regulation|August 1, 2022
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trialLeon Peto, Peter Horby, Martin Landray
Science Bulletin|February 28, 2022
COVID-19 can be called a treatable disease only after we have antiviralsXueyang Zhang, Peter Horby, Bin Cao
Emerging Infectious Diseases|January 23, 2019
International Biological Reference Preparations for Epidemic Infectious DiseasesTommy Rampling, Mark Page, Peter Horby
Lancet (London, England)|April 6, 2024
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' replyLeon Peto, Buddha Basnyat, Peter Horby
Vaccine|May 20, 2004
Using computer simulations to compare pertussis vaccination strategies in AustraliaHerbert W Hethcote, Peter Horby, Peter McIntyre
Singapore Medical Journal|October 3, 2014
The potential for a controlled human infection platform in SingaporeShobana Balasingam, Peter Horby, Annelies Wilder-Smith
Lancet (London, England)|April 11, 2008
Person-to-person transmission of influenza A (H5N1)Tran Hien Nguyen, Jeremy Farrar, Peter Horby
BMJ (Clinical Research Ed.)|October 2, 2009
Online video sharing and patients' privacyHeiman F L Wertheim, Jeremy Farrar, Peter Horby
Communicable Diseases Intelligence Quarterly Report|September 27, 2003
Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000Peter Horby, Robin Gilmour, Han Wang, et al.
Pageof 19